S'abonner

Attitudes and beliefs about COPD: Data from the BREATHE study - 04/01/13

Doi : 10.1016/S0954-6111(12)70015-X 
Abdullah Sayiner a, Ashraf Alzaabi b, Nathir M. Obeidat c, Chakib Nejjari d, Majed Beji e, Esra Uzaslan f, Salim Nafti g, Javaid Ahmed Khan h, Mohamed Awad Tageldin i, Majdy Idrees j, Nauman Rashid k, Abdelkader El Hasnaoui A, k,

on behalf of the BREATHE Study GroupB

  BREATHE Steering Committee members (in alphabetical order of names): Ashraf Alzaabi, Zayed Military Hospital, Abu Dhabi, UAE; Majed Beji, University of Tunis El Manar, Faculty of Medicine of Tunis, La Rabta Hospital, Tunis, Tunisia; Ali Ben Kheder, Abderrahmane Mami Hospital, Tunis, Tunisia; Majdy Idrees, Riyadh Military Hospital, Riyadh, Saudi Arabia; Ghali Iraqi, Moulay Youssef Hospital, Rabat, Morocco; Arshad Javed, Lady Reading Hospital, Peshawar, Pakistan; Javaid Ahmed Khan, Aga Khan University Hospital, Karachi, Pakistan; Adel Khattab, Ain Shams University, Cairo, Egypt; Marie Louise Koniski, Lebanese American University, Beirut, Lebanon; Bassam Mahboub, University of Sharjah, Sharjah, UAE; Salim Nafti, Mustapha Bacha Hospital, Algiers, Algeria; Nathir M. Obeidat, University of Jordan, Amman, Jordan; Mehmet Polatli, Adnan Menderes University, Aydin, Turkey; Abdullah Sayiner, Ege University, Izmir, Turkey; Naem Shahrour, Alasaad University Hospital, Damascus, Syria; Mohamed Awad Tageldin, Ain Shams University, Cairo, Egypt; Samya Taright, Bab-El-Oued Hospital, Algiers, Algeria; Esra Uzaslan, Uludag University Medical Faculty, Bursa, Turkey; Siraj Wali, King Abdulaziz University, Jeddah, Saudi Arabia.BREATHE core team members: Abdelkader El Hasnaoui, GlaxoSmithKline, Dubai, UAE; Nauman Rashid, GlaxoSmithKline, Dubai, UAE; Aïcha Lahlou, MS Health, Rabat, Morocco; Adam Doble, Foxymed, Paris, France, Hocine Salhi, Foxymed, Paris, France and Chakib Nejjari Faculty of Medicine of Fez, Fez, Morocco.

a Ege University, Izmir, Turkey 
b Zayed Military Hospital, Abu Dhabi, UAE 
c University of Jordan, Amman, Jordan 
d Faculty of Medicine of Fez, Fez, Morocco 
e La Rabta Hospital, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia 
f Uludag University Medical Faculty, Bursa, Turkey 
g Mustapha Bacha Hospital, Alger, Algeria 
h Aga Khan University Hospital, Karachi, Pakistan 
i Ain Shams University, Cairo, Egypt 
j Riyadh Military Hospital, Riyadh, Saudi Arabia 
k GlaxoSmithKline, Dubai, UAE 

* Corresponding author. Dr Abdelkader El Hasnaoui, GlaxoSmithKline, PO Box 50199, Dubai, United Arab Emirates. Tel.: +971 4 409 6305; fax: +971 4 332 3071

Summary

Although COPD is a debilitating pulmonary condition, many studies have shown awareness of the disease to be low. This article presents data on attitudes and beliefs about COPD in subjects with respiratory symptoms participating in the BREATHE study in the Middle East and North Africa region. This study was a large general population survey of COPD conducted in ten countries of the region (Algeria, Egypt, Jordan, Lebanon, Morocco, Saudi Arabia, Syria, Tunisia, Turkey and United Arab Emirates), together with Pakistan, using a standardised methodology. A total of 62,086 subjects were screened, of whom 2,187 fulfilled the “epidemiological” definition of COPD. A detailed questionnaire was administered to these subjects, which documented knowledge about the disease, attitudes to care, beliefs about COPD and satisfaction with treatment. 1,392 subjects were analysable. Overall, 58.6% of subjects claimed to be very well or adequately informed about their respiratory condition. Two-thirds of subjects reported receiving information about COPD from their physician and 10.6% from television; the internet was cited by 6% and other health professionals or patient associations by < 1%. Several inappropriate beliefs were identified, with 38.9% of respondents believing that there were no truly effective treatments, 73.7% believing that their respiratory condition would get progressively worse regardless of treatment and 29.6% being unsure what had caused their respiratory problems. Although 81% of respondents believed that smoking was the cause of most cases of COPD in general, only 51% accepted that it was the cause of their own respiratory problems. Treatment satisfaction was relatively high, with 83.2% of respondents somewhat or very satisfied with their physician’s management, in spite of the fact that only 47.5% considered that their physician’s advice had helped them manage their respiratory symptoms a lot. In conclusion, awareness of COPD in the region is suboptimal and treatment expectations are undervalued. Better patient education and more effective patient–physician communication are clearly required.

Le texte complet de cet article est disponible en PDF.

Keywords : Perception, Attitudes, Beliefs, COPD, Middle East, North Africa, BREATHE study, Education, Treatment satisfaction


Plan


 Conflict of interest statement
AS, AA, NMO, MB, EU, SN, JAK and MAT have received honoraria from GlaxoSmithKline Laboratories for their contribution to the BREATHE study. MI has received honoraria from GlaxoSmithKline Laboratories for his contribution to the BREATHE study and has received speaking honoraria from AstraZeneca, Novartis, Sanofi, MSD, Pfizer, Actelion and Bayer. CN advised on the data management and statistical analysis of the results of the BREATHE study on behalf of GlaxoSmithKline Laboratories. NR and AEH are employees of GlaxoSmithKline Laboratories, which funded the BREATHE study and market a number of treatments for COPD.


© 2012  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 106 - N° S2

P. S60-S74 - décembre 2012 Retour au numéro
Article précédent Article précédent
  • The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: Results of the BREATHE study
  • Esra Uzaslan, Bassam Mahboub, Majed Beji, Chakib Nejjari, Mohamed Awad Tageldin, Javaid Ahmed Khan, Salim Nafti, Nathir M. Obeidat, Abdullah Sayiner, Siraj Wali, Nauman Rashid, Abdelkader El Hasnaoui, on behalf of the BREATHE Study Group B
| Article suivant Article suivant
  • Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: The BREATHE study
  • Mehmet Polatli, Ali Ben Kheder, Siraj Wali, Arshad Javed, Adel Khattab, Bassam Mahboub, Ghali Iraqi, Chakib Nejjari, Samya Taright, Marie-Louise Koniski, Nauman Rashid, Abdelkader El Hasnaoui, on behalf of the BREATHE Study Group B

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.